Gain Therapeutics, Inc. Human Resources Contracts & Agreements
14 Contracts & Agreements
- Bonus & Incentive Agreements (2 contracts)
- Consulting Agreements (2)
- Employment Agreements (8)
- Separation Agreements (1)
- Transition Agreements (1)
- Employment Agreement, by and between the Company and Gene Mack, effective as of April 8, 2024 (Filed With SEC on April 8, 2024)
- Separation Agreement and Release, by and between GT Gain Therapeutics SA and Salvatore Calabrese, dated April 27, 2023 (Filed With SEC on April 28, 2023)
- Employment Agreement, by and between the Company and Evan Ballantyne, dated April 10, 2023 (Filed With SEC on April 12, 2023)
- Amended and Restated Employment Agreement, by and between the Company and Matthias Alder, dated September 20, 2022 (Filed With SEC on September 20, 2022)
- Transition Agreement, by and between the Company and Eric Richman, dated September 19, 2022 (Filed With SEC on September 20, 2022)
- Executive Employment Agreement, effective as of October 15, 2021, between Gain Therapeutics, Inc. and Matthias Alder (Filed With SEC on March 25, 2022)
- Gain Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (Filed With SEC on December 28, 2021)
- Executive Employment Agreement, effective as of October 15, 2021, between Gain Therapeutics, Inc. and Matthias Alder (Filed With SEC on November 12, 2021)
- 2020 Omnibus Incentive Plan(b) (Filed With SEC on March 10, 2021)
- Executive Employment Agreement, effective as of November 2, 2020, between Gain Therapeutics, Inc. and Salvatore Calabrese(b) (Filed With SEC on February 19, 2021)
- Consulting Agreement effective as of September 1, 2019, between GT Gain Therapeutics S.A. and Sal Calabrese (Filed With SEC on February 19, 2021)
- Consulting Agreement effective as of September 1, 2019, between GT Gain Therapeutics S.A. and Sal Calabrese (Filed With SEC on February 19, 2021)
- Executive Employment Agreement, effective as of August 13, 2020, between Gain Therapeutics, Inc. and Manolo Bellotto(b) (Filed With SEC on February 19, 2021)
- Executive Employment Agreement, effective as of July 20, 2020, between Gain Therapeutics, Inc. and Eric I. Richman(b) (Filed With SEC on February 19, 2021)
